Arlington Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.8K Hold
671
0.01% 229
2026
Q1
$64.9K Hold
671
0.01% 201
2025
Q4
$71.2K Hold
671
0.01% 175
2025
Q3
$85.2K Hold
671
0.02% 290
2025
Q2
$82.3K Hold
671
0.02% 288
2025
Q1
$68K Buy
671
+125
+23% +$12.2K 0.01% 321
2024
Q4
$50.4K Hold
546
0.01% 344
2024
Q3
$52.8K Hold
546
0.01% 327
2024
Q2
$46.8K Hold
546
0.01% 335
2024
Q1
$45.1K Buy
546
+231
+73% +$16.9K 0.01% 287
2023
Q4
$21K Buy
+315
New +$20.4K 0.01% 348

Other funds holding EHC

Arlington Trust's EHC Position: Q2 2026 in Review

Arlington Trust held its Encompass Health (EHC) position steady in Q2 2026 at 671 shares worth $67.8K. The position accounts for 0.01% of the portfolio, ranked #229.

Arlington Trust first reported a position in EHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $85.2K in Q3 2025. 81 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Arlington Trust held 671 shares of Encompass Health worth $67.8K as of Q2 2026.
  • Arlington Trust left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #229 holding.
  • Arlington Trust first reported a position in Encompass Health in Q4 2023 and has held it in 11 quarters since.
  • Arlington Trust's Encompass Health position peaked at $85.2K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.